 |
 |

Proteinuria, Renal Impairment, Metabolic Control, and Blood Pressure in Type 2 Diabetes MellitusA 14-Year Follow-up Report on 195 Patients
Mordchai Ravid, MD;
Hilel Savin, MD;
Ruth Lang, MD;
Itzhak Jutrin, MD;
Ludvinovsky Shoshana, MSc;
Michael Lishner, MD
Arch Intern Med. 1992;152(6):1225-1229.
Abstract
 |  |
Background. — The deleterious effect of hypertension on the course of diabetic retinopathy and the protective influence of antihypertensive therapy are well known. There is, however, little information about the long-term effect of different levels of blood pressure within the normal range on the evolution of renal function in type II diabetes.
Methods. — One hundred ninety-five young normotensive patients with recent-onset type II diabetes, normal renal function, and no proteinuria were followed up for 14 years. Plasma glucose, creatinine, and urinary protein levels and blood pressure were determined periodically.
Results.— Thirty patients developed hypertension; among them, 18 developed proteinuria (0.3 g/L). Among 144 patients who remained normotensive, 30 developed proteinuria. The mean decline in renal function (decline in reciprocal creatinine [100/creatinine level], expressed as a percentage of the initial value) was 26% for normotensive patients, 43% for normotensive patients with nephropathy, 39% for hypertensive patients, and 52% for hypertensive patients with nephropathy. The degree of metabolic control was not associated with the presence of proteinuria or with the severity of renal impairment. There was a significant association between the mean blood pressure over the whole observation period and the degree of impairment in renal function. This association was significant also in the patients who remained normotensive with and without proteinuria.
Conclusion.— Minor elevation of blood pressure as well as values in the upper normal range may be associated with acceleration of renal damage in type II diabetes.
(Arch Intern Med. 1992;152:1225-1229)
Author Affiliations
From the Department of Medicine, Sackler Faculty of Medicine, Tel Aviv University and Meir Hospital, Kfar-Saba, Israel.
Footnotes
Accepted for publication December 16, 1991.
Reprint requests to Meir Hospital, Kfar-Saba 44281, Israel (Dr Ravid).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Similar renal decline in diabetic and non-diabetic patients with comparable levels of albuminuria
Lorenzo et al.
Nephrol Dial Transplant 2009;0:gfp475v1-gfp475.
ABSTRACT
| FULL TEXT
Renal function and structure in albuminuric type 2 diabetic patients without retinopathy
Christensen et al.
Nephrol Dial Transplant 2001;16:2337-2347.
ABSTRACT
| FULL TEXT
Hypertension and Diabetes: New Therapeutic Options
Deedwania
Arch Intern Med 2000;160:1585-1594.
ABSTRACT
| FULL TEXT
Microalbuminuria in Nondiabetic Adults: Relation of Blood Pressure, Body Mass Index, Plasma Cholesterol Levels, and Smoking: The Gubbio Population Study
Cirillo et al.
Arch Intern Med 1998;158:1933-1939.
ABSTRACT
| FULL TEXT
Main Risk Factors for Nephropathy in Type 2 Diabetes Mellitus Are Plasma Cholesterol Levels, Mean Blood Pressure, and Hyperglycemia
Ravid et al.
Arch Intern Med 1998;158:998-1004.
ABSTRACT
| FULL TEXT
End-stage Renal Disease in Specific Ethnic and Racial Groups: Risk Factors and Benefits of Antihypertensive Therapy
Powers and Wallin
Arch Intern Med 1998;158:793-800.
ABSTRACT
| FULL TEXT
Blood Pressure and End-Stage Renal Disease in Men
Klag et al.
NEJM 1996;334:13-18.
ABSTRACT
| FULL TEXT
|